The groundbreaking therapy of this peptide represents a major advance in the care of diabetes mellitus type 2. Unlike existing drugs, tirzepatide impacts dual pathways – the GLP-1 hormone and GIP – leading to https://tirzepatide-peptide739220.anchor-blog.com/22416416/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment